Jaundice is one of the most common problems facing health care practioners in NICU. As we approach the 50th year of phototherapy this talk will explore some of the outstanding questions concerning diagnosis and treatment. Particular attention to the use of transcutaneous measurement and controversies pertaining to thresholds for treatment below 35 weeks gestational age will be discussed. Lastly we will explore how our current approach to jaundice may influence the risk of developing severe hyperbilirubinemia and chronic bilirubin encephalopathy (kernicterus) in a Canadian population.
Learning Objectives:
Objective 1: Understand how our approach to jaundice in term infants has influenced risk of neurologic injury over the last two decades.
Objective 2: Consider the merits of three different thresholds of treatment for hyperbilirubinemia in infants born at < 35 weeks gestational age.
Objective 3: Understand the impact of universal transcutaneous bilirubin screening in a Canadian health centre
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
